Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits
NCT ID: NCT04758299
Last Updated: 2021-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
360 participants
INTERVENTIONAL
2021-03-13
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers
NCT05812599
Covid-19 Messaging to Underserved Communities - 2nd Experiment
NCT04502056
Impact of a Decision Aid Regarding Natural Health Products for Menopausal Symptoms
NCT00325923
Informing Decisions in Chronic Critical Illness: A Randomized Control Trial (RCT)
NCT01230099
Effect of Modality on Discharge Instruction in Patients Receiving Outpatient Antibiotic Prescriptions From the Emergency Department
NCT01775969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized to receive either information from the FDA authorized Ellume home test kit for what actions to take for a negative or positive COVID-19 test (usual care) or a decision science-based design of similar length (intervention). They will be given time to read the documents and the opportunity to download a full "instructions for use" document (the FDA authorized for the ELLUME test kit). They will then be randomized to one of four conditions, asking them to imagine a clinical context: a person with no symptoms and no close COVID-19 contact, no symptoms and close contact,
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
There are 4 groups (clinical scenarios) within each randomized arm (the scenarios are patient with no symptoms and no exposure; no symptoms and exposure; symptoms and no exposure; symptoms and exposure.
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard care
information from an FDA authorized home test kit for what actions to take for a negative or positive COVID-19 test
No interventions assigned to this group
Decision science-based design
Information from a decision science-based design (of similar length to the FDA authorized home test kit information) for what actions to take for a negative or positive COVID-19 test
decision science-based design
decision science-based design explaining actions to take for a negative or positive COVID-19 test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
decision science-based design
decision science-based design explaining actions to take for a negative or positive COVID-19 test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dartmouth College
OTHER
University of Pittsburgh
OTHER
Barry Dewitt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barry Dewitt
Postdoctoral Research Associate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry Dewitt
Role: PRINCIPAL_INVESTIGATOR
Carnegie Mellon University
Steven Woloshin, MD
Role: PRINCIPAL_INVESTIGATOR
Dartmouth College
Tamar Krishnamurti, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Baruch Fischhoff, PhD
Role: PRINCIPAL_INVESTIGATOR
Carnegie Mellon University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carnegie Mellon University
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Woloshin S, Dewitt B, Krishnamurti T, Fischhoff B. Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial. JAMA Intern Med. 2022 Mar 1;182(3):332-341. doi: 10.1001/jamainternmed.2021.8075.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY2020_501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.